Chemo-Immunotherapy Regimes for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis by Youwen Zhu, Kun Liu, Dong Ding, Kailing Wang, Xiaoting Liu, Xiao Tan

Subjects: “…recurrent or metastatic nasopharyngeal carcinoma…”
Get full text

Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-anal... by Jian Luo, Wanying Xiao, Fengyang Hua, Yanqing Cao, Dongxia Wang, Xicheng Wang

Subjects: “…Recurrent or metastatic nasopharyngeal carcinoma…”
Get full text

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for recurrent or metastatic nasopharyngeal cancer by Zhengda Pei, Zhengda Pei, Ningping Xiao, Ningping Xiao, Pei Yang, Pei Yang, Pei Yang

Subjects: “…recurrent or metastatic nasopharyngeal carcinoma…”
Get full text

Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma by Chen Chen, Yixin Zhou, Xuanye Zhang, Sha Fu, Zuan Lin, Wenfeng Fang, Yunpeng Yang, Yan Huang, Hongyun Zhao, Shaodong Hong, Li Zhang

Subjects: Get full text